Literature DB >> 17418982

Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines.

Veronika Ullmannova1, Nicholas C Popescu.   

Abstract

BACKGROUND: Dietary flavone was previously shown to increase the expression of deleted in liver cancer-1 gene (DLC-1) in HT-29 colon carcinoma cell line [Herzog A, Kindermann B, Doring F, Daniel H, Wenzel U. Pleiotropic molecular effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identified by protein and mRNA expression profiling. Proteomics 2004;4:2455-64]. DLC-1 that encodes a Rho GTPase-activating protein, functions as a tumor suppressor gene and is frequently inactivated or down-regulated in several common cancers. Restoration of DLC-1 expression suppresses in vitro tumor cells proliferation and tumorigenicity in vivo.
METHODS: Here, the effect of flavone was examined in several DLC-1-deficient cell lines derived from different types human cancer using assays for cell proliferation, gene expression and transfer.
RESULTS: We show that exposure to 150 microM flavone increased DLC1 expression in breast but not in liver or prostate carcinoma cells or a nonmalignant breast epithelial cell line. Flavone restored the expression of DLC1 in the breast carcinoma cell lines MDA-MB-468, MDA-MB-361, and BT20 as well as in the colon carcinoma cell line HT-29 all of which are DLC-1-negative due to promoter hypermethylation. We further show that flavone inhibited cell proliferation, induced cell cycle arrest at G(2)-M, increased p21(Waf1) gene expression, and caused apoptosis. Microarray analysis of these aggressive and metastatic breast carcinoma cells revealed 29 flavone-responsive genes, among which the DNA damage-inducible GADD genes were up-regulated and the proto-oncogene STMN1 and IGFBP3 were down-regulated.
CONCLUSIONS: Flavone-mediated alterations of genes that regulate tumor cell proliferation, cell cycle, and apoptosis contribute to chemopreventive and antitumoral effects of flavone. Alone or in combination with demethylating agents, flavone may be an effective adjunct to chemotherapy in preventing breast cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418982      PMCID: PMC1950447          DOI: 10.1016/j.cdp.2007.02.005

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  51 in total

1.  The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes.

Authors:  D M Lepley; B Li; D F Birt; J C Pelling
Journal:  Carcinogenesis       Date:  1996-11       Impact factor: 4.944

2.  Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function.

Authors:  R L Ludwig; S Bates; K H Vousden
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

3.  Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro.

Authors:  D T Zava; G Duwe
Journal:  Nutr Cancer       Date:  1997       Impact factor: 2.900

4.  Pleiotropic molecular effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identified by protein and mRNA expression profiling.

Authors:  Angelika Herzog; Birgit Kindermann; Frank Döring; Hannelore Daniel; Uwe Wenzel
Journal:  Proteomics       Date:  2004-08       Impact factor: 3.984

Review 5.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

6.  Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines.

Authors:  Cécile Vissac-Sabatier; Yves-Jean Bignon; Dominique J Bernard-Gallon
Journal:  Nutr Cancer       Date:  2003       Impact factor: 2.900

7.  Genistein arrests cell cycle progression at G2-M.

Authors:  Y Matsukawa; N Marui; T Sakai; Y Satomi; M Yoshida; K Matsumoto; H Nishino; A Aoike
Journal:  Cancer Res       Date:  1993-03-15       Impact factor: 12.701

8.  Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells.

Authors:  M C Pagliacci; M Smacchia; G Migliorati; F Grignani; C Riccardi; I Nicoletti
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

9.  Apigenin induces morphological differentiation and G2-M arrest in rat neuronal cells.

Authors:  F Sato; Y Matsukawa; K Matsumoto; H Nishino; T Sakai
Journal:  Biochem Biophys Res Commun       Date:  1994-10-28       Impact factor: 3.575

10.  Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.

Authors:  R L Rocha; S G Hilsenbeck; J G Jackson; A V Lee; J A Figueroa; D Yee
Journal:  J Natl Cancer Inst       Date:  1996-05-01       Impact factor: 13.506

View more
  16 in total

1.  DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.

Authors:  Rakesh Joshi; Lyugao Qin; Xuan Cao; Shanshan Zhong; Courtney Voss; Weiping Min; Shawn S C Li
Journal:  J Biol Chem       Date:  2019-12-05       Impact factor: 5.157

2.  Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.

Authors:  Yufei Liu; Jun Zhou; Yuchang Hu; Junjie Wang; Chengfu Yuan
Journal:  Mol Cell Biochem       Date:  2016-11-10       Impact factor: 3.396

3.  DLC-1 as a modulator of proliferation, apoptosis and migration in Burkitt's lymphoma cells.

Authors:  Minhua Feng; Bo Huang; Zunguo Du; Xiaoping Xu; Zi Chen
Journal:  Mol Biol Rep       Date:  2010-10-01       Impact factor: 2.316

4.  Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.

Authors:  Wenzhen Zhu; Long Ma; Bingwu Yang; Zhaodi Zheng; Rongfei Chai; Tingting Liu; Zhaojun Liu; Taiyu Song; Fenglin Li; Guorong Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-03-02       Impact factor: 2.416

Review 5.  Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.

Authors:  Nicholas C Popescu; Steve Goodison
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

6.  Identification of flavone glucuronide isomers by metal complexation and tandem mass spectrometry: regioselectivity of uridine 5'-diphosphate-glucuronosyltransferase isozymes in the biotransformation of flavones.

Authors:  Scott A Robotham; Jennifer S Brodbelt
Journal:  J Agric Food Chem       Date:  2013-02-08       Impact factor: 5.279

Review 7.  Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.

Authors:  Yi-Chun Liao; Su Hao Lo
Journal:  Int J Biochem Cell Biol       Date:  2007-04-20       Impact factor: 5.085

8.  The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decrease.

Authors:  Ewa Toton; Natalia Lisiak; Blazej Rubis; Jaromir Budzianowski; Peter Gruber; Johann Hofmann; Maria Rybczynska
Journal:  Eur J Pharmacol       Date:  2012-02-21       Impact factor: 4.432

9.  Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissues.

Authors:  Ning Li; Yunzhu Long; Xuegong Fan; Hongbo Liu; Cui Li; Lizhang Chen; Zhiming Wang
Journal:  J Exp Clin Cancer Res       Date:  2009-08-28

Review 10.  Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).

Authors:  Drazen B Zimonjic; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2012-05-10       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.